DK3365346T3 - Oxa-diazaspiroforbindelser med aktivitet mod smerter - Google Patents

Oxa-diazaspiroforbindelser med aktivitet mod smerter Download PDF

Info

Publication number
DK3365346T3
DK3365346T3 DK16784795.3T DK16784795T DK3365346T3 DK 3365346 T3 DK3365346 T3 DK 3365346T3 DK 16784795 T DK16784795 T DK 16784795T DK 3365346 T3 DK3365346 T3 DK 3365346T3
Authority
DK
Denmark
Prior art keywords
oxa
activity against
against pain
diazaspiro compounds
diazaspiro
Prior art date
Application number
DK16784795.3T
Other languages
English (en)
Inventor
Marina Virgili-Bernado
Carmen Almansa-Rosales
Carlos Alegret-Molina
Original Assignee
Esteve Pharmaceuticals Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Pharmaceuticals Sa filed Critical Esteve Pharmaceuticals Sa
Application granted granted Critical
Publication of DK3365346T3 publication Critical patent/DK3365346T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK16784795.3T 2015-10-23 2016-10-21 Oxa-diazaspiroforbindelser med aktivitet mod smerter DK3365346T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15382523 2015-10-23
PCT/EP2016/001742 WO2017067664A1 (en) 2015-10-23 2016-10-21 Oxa-diazaspiro compounds having activity against pain

Publications (1)

Publication Number Publication Date
DK3365346T3 true DK3365346T3 (da) 2020-03-09

Family

ID=54364221

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16784795.3T DK3365346T3 (da) 2015-10-23 2016-10-21 Oxa-diazaspiroforbindelser med aktivitet mod smerter

Country Status (30)

Country Link
US (1) US10689398B2 (da)
EP (1) EP3365346B1 (da)
JP (1) JP6884973B2 (da)
KR (1) KR20180073638A (da)
CN (1) CN108349998B (da)
AR (1) AR106448A1 (da)
AU (1) AU2016343551A1 (da)
BR (1) BR112018007269A2 (da)
CA (1) CA2999925A1 (da)
CO (1) CO2018004803A2 (da)
CY (1) CY1122708T1 (da)
DK (1) DK3365346T3 (da)
ES (1) ES2775522T3 (da)
HR (1) HRP20200309T1 (da)
HU (1) HUE047997T2 (da)
IL (1) IL258370A (da)
LT (1) LT3365346T (da)
MA (1) MA43158B1 (da)
ME (1) ME03636B (da)
MX (1) MX2018004777A (da)
PH (1) PH12018500682A1 (da)
PL (1) PL3365346T3 (da)
PT (1) PT3365346T (da)
RS (1) RS59956B1 (da)
RU (1) RU2018118399A (da)
SG (1) SG11201802988XA (da)
SI (1) SI3365346T1 (da)
TN (1) TN2018000091A1 (da)
TW (1) TW201731853A (da)
WO (1) WO2017067664A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201615643A (zh) 2014-06-02 2016-05-01 伊史帝夫博士實驗室股份有限公司 具有多重模式抗疼痛活性之１－氧雜－４，９－二氮雜螺十一烷化合物之烷基與芳基衍生物
MX2018004777A (es) 2015-10-23 2018-06-19 Esteve Labor Dr Compuestos oxa-diazaspiro que tienen actividad contra el dolor.

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3481942A (en) 1968-09-06 1969-12-02 Smithkline Corp Oxa-diazaspiro(4.5)decane compounds
US4353900A (en) * 1981-10-19 1982-10-12 Syntex (U.S.A.) Inc. 9-(Arylalkyl or aroylalkyl)-1-oxa-4,9-diazaspiro(5.5)undecan-3-ones
WO1993013101A1 (en) * 1991-12-27 1993-07-08 Yoshitomi Pharmaceutical Industries, Ltd. Pyridonecarboxylate compound, pharmaceutical use thereof, and spiro compound
US6114541A (en) 1997-03-10 2000-09-05 Hoffmann-La Roche Inc. Method for the preparation of α-Bromo-Lactam derivatives
KR100974901B1 (ko) 2001-12-28 2010-08-10 아카디아 파마슈티칼스 인코포레이티드 모노아민 수용체 조정자로서의 스피로아자사이클릭 화합물
CA2543820C (en) * 2003-11-07 2012-07-10 Chiron Corporation Methods for synthesizing quinolinone compounds
EP1634873A1 (en) 2004-08-27 2006-03-15 Laboratorios Del Dr. Esteve, S.A. Sigma receptor inhibitors
DE102005030051A1 (de) 2005-06-27 2006-12-28 Grünenthal GmbH Substituierte 1-Oxa-3,8-diazaspiro[4,5]-decan-2-on-Verbindungen und deren Verwendung zur Herstellung von Arzneimitteln
US8168783B2 (en) 2005-11-18 2012-05-01 Ono Pharmaceutical Co., Ltd. Chemokine receptor antagonists and use thereof
EP1829869A1 (en) 2006-03-02 2007-09-05 Laboratorios Del Dr. Esteve, S.A. 4,5,6,7-Tetrahydrobenzo[b]thiophene derivatives and their use as sigma receptor ligands
WO2007124136A1 (en) 2006-04-19 2007-11-01 Acadia Pharmaceuticals, Inc. Use of 4-amino-piperidines for treating sleep disorders
EP1847542A1 (en) 2006-04-21 2007-10-24 Laboratorios del Dr. Esteve S.A. Spiro[benzopyran] or spiro[benzofuran] derivatives which inhibit the sigma receptor
ES2541133T3 (es) 2007-03-01 2015-07-16 Mitsubishi Tanabe Pharma Corporation Compuesto de bencimidazol y uso farmacéutico del mismo
EP1982714A1 (en) 2007-04-16 2008-10-22 Laboratorios del Dr. Esteve S.A. Pyrano-pyrazole-amines
EP2020414A1 (en) 2007-06-20 2009-02-04 Laboratorios del Dr. Esteve S.A. spiro[piperidine-4,4'-thieno[3,2-c]pyran] derivatives and related compounds as inhibitors of the sigma receptor for the treatment of psychosis
EP2197876A1 (en) 2007-08-29 2010-06-23 Glaxosmithkline LLC Thiazole and oxazole kinase inhibitors
EP2070933A1 (en) 2007-12-07 2009-06-17 Laboratorios del Dr. Esteve S.A. Tricyclic triazolic compounds
UA100400C2 (uk) 2008-02-06 2012-12-25 Астразенека Аб Похідні спіроциклічних амідів
KR101691836B1 (ko) 2009-10-25 2017-01-02 엘지전자 주식회사 프로그램 정보 처리 방법 및 방송 수신기
ES2618929T3 (es) * 2011-03-14 2017-06-22 Vertex Pharmaceuticals Incorporated Morfolina-Spiro piperidina amida cíclica como moduladores del canal iónico
US8940085B2 (en) 2011-03-16 2015-01-27 Access Business Group International Llc Humidifier with ultraviolet disinfection
ES2608053T3 (es) 2011-08-19 2017-04-05 Glaxosmithkline Intellectual Property (No. 2) Limited Inhibidores de ácido graso sintasa
US9751881B2 (en) 2013-07-31 2017-09-05 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
JP2017100951A (ja) 2014-04-04 2017-06-08 大正製薬株式会社 オキサゾリジノン及びオキサジナノン誘導体
TW201615643A (zh) * 2014-06-02 2016-05-01 伊史帝夫博士實驗室股份有限公司 具有多重模式抗疼痛活性之１－氧雜－４，９－二氮雜螺十一烷化合物之烷基與芳基衍生物
TW201615642A (zh) 2014-06-02 2016-05-01 伊史帝夫博士實驗室股份有限公司 具有多重模式抗疼痛活性的１－氧雜－４，９－二氮雜螺十一烷化合物之醯胺衍生物
TWI685497B (zh) 2014-06-02 2020-02-21 西班牙商伊史帝夫製藥公司 具有多重模式抗疼痛活性的１-氧雜-４,９-二氮雜螺十一烷化合物之烷基衍生物
US10022359B2 (en) 2014-11-21 2018-07-17 Esteve Pharmaceuticals, S.A. 1,9-diazaspiro undecane compounds having multimodal activity against pain
MX2018004777A (es) 2015-10-23 2018-06-19 Esteve Labor Dr Compuestos oxa-diazaspiro que tienen actividad contra el dolor.

Also Published As

Publication number Publication date
HRP20200309T1 (hr) 2020-06-12
PT3365346T (pt) 2020-03-05
WO2017067664A9 (en) 2017-06-29
ES2775522T3 (es) 2020-07-27
EP3365346A1 (en) 2018-08-29
RU2018118399A (ru) 2019-11-25
TN2018000091A1 (en) 2019-07-08
WO2017067664A1 (en) 2017-04-27
LT3365346T (lt) 2020-04-10
TW201731853A (zh) 2017-09-16
CA2999925A1 (en) 2017-04-27
JP2018531263A (ja) 2018-10-25
US20190002475A1 (en) 2019-01-03
IL258370A (en) 2018-05-31
CO2018004803A2 (es) 2018-07-19
BR112018007269A2 (pt) 2018-10-30
CY1122708T1 (el) 2021-03-12
ME03636B (me) 2020-07-20
HUE047997T2 (hu) 2020-05-28
KR20180073638A (ko) 2018-07-02
PL3365346T3 (pl) 2020-06-01
SI3365346T1 (sl) 2020-04-30
MX2018004777A (es) 2018-06-19
MA43158B1 (fr) 2020-03-31
US10689398B2 (en) 2020-06-23
SG11201802988XA (en) 2018-05-30
CN108349998A (zh) 2018-07-31
RS59956B1 (sr) 2020-03-31
JP6884973B2 (ja) 2021-06-09
CN108349998B (zh) 2021-10-29
AU2016343551A1 (en) 2018-04-19
RU2018118399A3 (da) 2020-01-31
EP3365346B1 (en) 2019-12-04
AR106448A1 (es) 2018-01-17
PH12018500682A1 (en) 2018-10-01

Similar Documents

Publication Publication Date Title
DK3174868T3 (da) Forbindelser, der er aktive mod bromodomæner
BR112017018843A2 (pt) combinações de composto fungicidamente ativo
DK3240773T3 (da) Picolinamidforbindelser med fungicid aktivitet
DK3010910T3 (da) Pyrimidindionforbindelser mod hjertetilstande
DK3400926T3 (da) Stimulationsindretning med forlængelse
DK3474804T4 (da) Medicinsk forbinding
ITUB20153010A1 (it) Pennello perfezionato
DK3337795T3 (da) Piperidinobenzodiazepinforbindelser med anti-proliferativ aktivitet
DK3393478T3 (da) Kombinationsterapi
DK3373874T4 (da) Medicinsk forbinding
DK3167052T3 (da) P450-bm3-varianter med forbedret aktivitet
BR112017013013A2 (pt) combinações de composto ativo
DK3359083T3 (da) Tandbørste
DK3370794T3 (da) Antimikrobielle opløsninger med forbedret stabilitet
ES1141731Y (es) Cepillo de Dientes
DK3352735T3 (da) Olanzapinformuleringer med langvarig frigivelse
DK3331600T3 (da) Kateter
DK3365346T3 (da) Oxa-diazaspiroforbindelser med aktivitet mod smerter
PT3365338T (pt) Derivados de morfolina substituídos tendo atividade contra a dor
DE112016001834A5 (de) Kanüle
DK3484852T3 (da) Benzo-n-hydroxyamidforbindelser med antitumor-aktivitet
DK3359102T3 (da) Medicinsk plaster
DK3244861T3 (da) Tandlægeunit
PT3365345T (pt) Composto de oxa- azaespiro tendo atividade contra a dor
DK3371522T3 (da) Transpireret solfanger